CHA2DS2-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting

Jian-Yong Zheng1, Dong-Tao Li1, Yi-Gang Qıu1

  • 1Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, Sixth Medical Center of PLA General Hospital, Beijing, China.

Insights

The CHA2DS2-VASc score accurately predicts adverse outcomes in patients with atrial fibrillation (AF) and coronary stenting. Higher scores correlate with increased risks of death, stroke, and major adverse cardiac events, confirming its prognostic value.

Area of Science:

  • Cardiology
  • Clinical Research
  • Medical Informatics

Background:

  • Patients with atrial fibrillation (AF) and coronary stenting face poor prognoses.
  • Assessing predictive accuracy of the CHA2DS2-VASc score in this high-risk population is crucial.

Approach:

  • Retrospective review of 2394 patients with nonvalvular AF undergoing coronary stenting (2010-2015).
  • Patients stratified into low (≤2), intermediate (3-4), and high (≥5) CHA2DS2-VASc score groups.
  • Major adverse cardiac/cerebrovascular events (MACCE) defined as composite of death, myocardial infarction, revascularization, and ischemic stroke/systemic thromboembolism (IS/SE).

Key Points:

  • All-cause mortality tripled from low to high CHA2DS2-VASc score groups (4.8% vs. 15.8%).
  • High score group (≥5) showed increased IS/SE (7.4%) and MACCE (26.3%).
  • CHA2DS2-VASc score ≥5 independently predicted all-cause death (HR 2.303), IS/SE (HR 4.169), and MACCE (HR 1.468).

Conclusions:

  • The CHA2DS2-VASc score demonstrates reliability in predicting adverse clinical outcomes for patients with AF and coronary stenting.
  • This score aids in risk stratification and management decisions for this vulnerable patient cohort.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
95
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
19
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
46